| Date Filed | Type | Description |
| 04/04/2023 |
4
| COHEN RON (President and CEO) has filed a Form 4 on Acorda Therapeutics, Inc.|
Txns:
| Granted 168,800 options to buy
@ $0.586, valued at
$98.9k
|
|
| 03/20/2023 |
4
| COHEN RON (President and CEO) has filed a Form 4 on Acorda Therapeutics, Inc.|
Txns:
| Bought 10,156 shares
@ $0.6, valued at
$6.1k
Bought 10,000 shares
@ $0.65, valued at
$6.5k
|
|
| 03/21/2022 |
4
| COHEN RON (President and CEO) has filed a Form 4 on ACORDA THERAPEUTICS INC|
Txns:
| Sold 2,289 shares
@ $1.7014, valued at
$3.9k
|
|
| 09/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/21/2020 |
4
| COHEN RON (President and CEO) has filed a Form 4 on ACORDA THERAPEUTICS INC|
Txns:
| Granted 8,543 shares
@ $0 |
|
| 12/04/2019 |
4
| COHEN RON (President and CEO) has filed a Form 4 on ACORDA THERAPEUTICS INC|
Txns:
| Sold 4,699 shares
@ $1.5972, valued at
$7.5k
|
|
| 11/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/12/2019 |
4
| COHEN RON (President and CEO) has filed a Form 4 on ACORDA THERAPEUTICS INC|
Txns:
| Granted 25,629 shares
@ $0
Granted 42,715 options to buy
@ $13.51, valued at
$577.1k
|
|
| 02/25/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/27/2018 |
4
| COHEN RON (President and CEO) has filed a Form 4 on ACORDA THERAPEUTICS INC|
Txns:
| Granted 5,980 shares
@ $0 |
|
| 12/06/2018 |
4
| COHEN RON (President and CEO) has filed a Form 4 on ACORDA THERAPEUTICS INC|
Txns:
| Sold 3,620 shares
@ $20.5951, valued at
$74.6k
|
|
| 11/07/2018 |
4
| COHEN RON (President and CEO) has filed a Form 4 on ACORDA THERAPEUTICS INC|
Txns:
| Paid exercise price by delivering 2,031 shares
@ $20.28, valued at
$41.2k
|
|
| 09/12/2018 |
4
| COHEN RON (President and CEO) has filed a Form 4 on ACORDA THERAPEUTICS INC|
Txns:
| Granted 5,980 shares
@ $0 |
|
| 03/07/2018 |
4
| COHEN RON (President and CEO) has filed a Form 4 on ACORDA THERAPEUTICS INC|
Txns:
| Paid exercise price by delivering 24,590 shares
@ $25.95, valued at
$638.1k
Exercised 62,500 options to buy
@ $19.81, valued at
$1.2M
|
|
| 02/26/2018 |
4
| COHEN RON (President and CEO) has filed a Form 4 on ACORDA THERAPEUTICS INC|
Txns:
| Granted 14,727 shares
@ $0 |
|
| 06/20/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/16/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/05/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/04/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/04/2013 |
4
| COHEN RON (President and CEO) has filed a Form 4 on ACORDA THERAPEUTICS INC|
Txns:
| Sold 18,125 shares
@ $33.5155, valued at
$607.5k
|
|
| 08/20/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/12/2013 |
4
| COHEN RON (President and CEO) has filed a Form 4 on ACORDA THERAPEUTICS INC|
Txns:
| Sold 11,000 shares
@ $34.15, valued at
$375.7k
|
|
| 03/08/2013 |
4
| COHEN RON (President and CEO) has filed a Form 4 on ACORDA THERAPEUTICS INC|
Txns:
| Granted 22,500 shares
@ $0
Granted 127,500 options to buy
@ $30.46, valued at
$3.9M
|
|
| 03/19/2012 |
4
| COHEN RON (President and CEO) has filed a Form 4 on ACORDA THERAPEUTICS INC|
Txns:
| Granted 37,500 shares
@ $0
Granted 112,500 options to buy
@ $26.35, valued at
$3M
|
|
| 12/05/2011 |
4
| COHEN RON (President and CEO) has filed a Form 4 on ACORDA THERAPEUTICS INC|
Txns:
| Sold 16,500 shares
@ $22.92, valued at
$378.2k
|
|
| 11/03/2011 |
4
| COHEN RON (Director) has filed a Form 4 on DYAX CORP|
Txns:
| Granted 25,000 options to buy
@ $1.35, valued at
$33.8k
|
|
| 11/03/2011 |
3
| COHEN RON (Director) has filed a Form 3 on DYAX CORP |
| 06/09/2011 |
4
| COHEN RON (President and CEO) has filed a Form 4 on ACORDA THERAPEUTICS INC|
Txns:
| Sold 12,000 shares
@ $30.87, valued at
$370.4k
|
|
| 05/31/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/07/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/03/2010 |
4
| COHEN RON (President and CEO) has filed a Form 4 on ACORDA THERAPEUTICS INC|
Txns:
| Sold 4,100 shares
@ $26.89, valued at
$110.2k
Sold 10,900 shares
@ $26.4, valued at
$287.8k
|
|
| 08/24/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|